Literature DB >> 26066838

The Role of HMGB1 in Cardiovascular Biology: Danger Signals.

Jingjing Cai1,2,3, Juan Wen1,3, Eileen Bauer2, Hua Zhong1,2,3, Hong Yuan1,3, Alex F Chen1,2.   

Abstract

SIGNIFICANCE: Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Accumulating evidence shows that dysregulated immune response contributes to several types of CVDs such as atherosclerosis and pulmonary hypertension (PH). Vascular intimal impairment and low-density lipoprotein oxidation trigger a complex network of innate immune responses and sterile inflammation. RECENT ADVANCES: High-mobility group box 1 (HMGB1), a nuclear DNA-binding protein, was recently discovered to function as a damage-associated molecular pattern molecule (DAMP) that initiates the innate immune responses. These findings lead to the understanding that HMGB1 plays a critical role in the inflammatory response in the pathogenesis of CVD. CRITICAL ISSUES: In this review, we highlight the role of extracellular HMGB1 as a proinflammatory mediator as well as a DAMP in coronary artery disease, cerebral artery disease, peripheral artery disease, and PH. FUTURE DIRECTIONS: A key focus for future researches on HMGB1 location, structure, modification, and signaling will reveal HMGB1's multiple functions and discover a targeted therapy that can eliminate HMGB1-mediated inflammation without interfering with adaptive immune responses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26066838     DOI: 10.1089/ars.2015.6408

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  31 in total

1.  HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.

Authors:  Jingjing Cai; Hong Yuan; Qingde Wang; Huan Yang; Yousef Al-Abed; Zhong Hua; Jiemei Wang; Dandan Chen; Jinze Wu; Ben Lu; John P Pribis; Weihong Jiang; Kan Yang; David J Hackam; Kevin J Tracey; Timothy R Billiar; Alex F Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-29       Impact factor: 8.311

Review 2.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

3.  Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.

Authors:  Jingjing Cai; Hua Zhong; Jinze Wu; Rui-Fang Chen; Huan Yang; Yousef Al-Abed; Ying Li; Xiaohui Li; Weihong Jiang; Marcelo Freitas Montenegro; Hong Yuan; Timothy Billiar; Alex F Chen
Journal:  Mol Med       Date:  2016-03-20       Impact factor: 6.354

4.  High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention.

Authors:  Changhua Mo; Xiao Ma; Wen Jian; Qili Huang; Wenbo Zheng; Zhijie Yang; Yutao Xu; Chun Gui
Journal:  Int Urol Nephrol       Date:  2021-11-02       Impact factor: 2.370

Review 5.  Trained Immunity as a Trigger for Atherosclerotic Cardiovascular Disease-A Literature Review.

Authors:  Natalia Anna Zieleniewska; Małgorzata Kazberuk; Małgorzata Chlabicz; Andrzej Eljaszewicz; Karol Kamiński
Journal:  J Clin Med       Date:  2022-06-12       Impact factor: 4.964

6.  HMGB1-Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice.

Authors:  Xin-Lin Zhang; Ting-Yu Wang; Zheng Chen; Hong-Wei Wang; Yong Yin; Lian Wang; Yong Wang; Biao Xu; Wei Xu
Journal:  J Am Heart Assoc       Date:  2022-02-12       Impact factor: 6.106

7.  PDGFR-β signaling mediates HMGB1 release in mechanically stressed vascular smooth muscle cells.

Authors:  Ji On Kim; Seung Eun Baek; Eun Yeong Jeon; Jong Min Choi; Eun Jeong Jang; Chi Dae Kim
Journal:  PLoS One       Date:  2022-03-16       Impact factor: 3.240

8.  HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization.

Authors:  Qiang Chen; Jun-Jie Bei; Chuan Liu; Shi-Bin Feng; Wei-Bo Zhao; Zhou Zhou; Zheng-Ping Yu; Xiao-Jun Du; Hou-Yuan Hu
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

9.  MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1.

Authors:  Yi Wang; Min Ouyang; Qiong Wang; Zaijin Jian
Journal:  Int J Mol Med       Date:  2016-09-28       Impact factor: 4.101

Review 10.  Multiple inducers of endothelial NOS (eNOS) dysfunction in sickle cell disease.

Authors:  Robert P Hebbel; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2021-08-23       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.